An amphipol‐stabilized multi‐pass transmembrane protein as an immunogen to generate mouse memory B cells against native <scp>VMAT</scp> 2

Multi-pass transmembrane proteins (MPTPs) are essential for sensing and processing cellular signals and are the primary drug targets of more than half of the approved drugs, the majority being small molecules. However, monoclonal antibodies with favorable properties in modulating MPTPs are rare. Such antibody discovery is limited by the challenging preparation of correctly folded antigens and the generation of antibodies against the natural conformation of MPTPs. Here, we developed an amphipol-trapped antigen as an immunogen and induced efficient mouse memory B cell responses. We generated antibodies unbiasedly by culturing single memory B cells and characterized their specificities. We implemented our strategy to generate high-affinity antibodies against the native conformation of vesicular monoamine transporter 2 (VMAT2; also known as SLC18A2), demonstrating the potential use in discovering antibodies against MPTPs for therapeutics.

Authors

Institutions

Publication Details

Journal
FEBS Letters
Published
2025-06-17
DOI
https://doi.org/10.1002/1873-3468.70092
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An amphipol‐stabilized multi‐pass transmembrane protein as an immunogen to generate mouse memory B cells against native VMAT 2

Jie Shen, Yong-Mei Xing, Hongwu Qian, Pei Tong et al.
FEBS Letters
Immune Cell Function and Interaction
article

An amphipol‐stabilized multi‐pass transmembrane protein as an immunogen to generate mouse memory B cells against native VMAT 2

Jie Shen, Yong-Mei Xing, Hongwu Qian, Pei Tong, Jiping Yang, Shengyan Kong, Zhenhua Wang, Tao Liu, Xiaohua He, Jingjing He
article en

Abstract

Multi-pass transmembrane proteins (MPTPs) are essential for sensing and processing cellular signals and are the primary drug targets of more than half of the approved drugs, the majority being small molecules. However, monoclonal antibodies with favorable properties in modulating MPTPs are rare. Such antibody discovery is limited by the challenging preparation of correctly folded antigens and the generation of antibodies against the natural conformation of MPTPs. Here, we developed an amphipol-trapped antigen as an immunogen and induced efficient mouse memory B cell responses. We generated antibodies unbiasedly by culturing single memory B cells and characterized their specificities. We implemented our strategy to generate high-affinity antibodies against the native conformation of vesicular monoamine transporter 2 (VMAT2; also known as SLC18A2), demonstrating the potential use in discovering antibodies against MPTPs for therapeutics.

FEBS LettersVol. 599(18)
University of Science and Technology of China (CN), Anhui Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 85%
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

An amphipol‐stabilized multi‐pass transmembrane protein as an immunogen to generate mouse memory B cells against native <scp>VMAT</scp> 2 — Jie Shen, Yong-Mei Xing, et al. · FEBS Letters (2025) | TGRS Research Map | TGRS